These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 30807747

  • 21. Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.
    Chen G, Zhang Y, Liu X, Fang Q, Wang Z, Fu L, Liu Z, Wang Y, Zhao Y, Li X, Liang G.
    J Med Chem; 2016 Mar 24; 59(6):2436-51. PubMed ID: 26937738
    [Abstract] [Full Text] [Related]

  • 22. 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2.
    Ouyang W, Zhou H, Liu C, Wang S, Han Y, Xia J, Xu F.
    J Cell Mol Med; 2018 Nov 24; 22(11):5494-5503. PubMed ID: 30091835
    [Abstract] [Full Text] [Related]

  • 23. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C, Chen G, Yang W, Xu Y, Xu Y, Huang X, Liu J, Feng Y, Xu Y, Liu B.
    Int Immunopharmacol; 2015 Oct 24; 28(2):1050-8. PubMed ID: 26321117
    [Abstract] [Full Text] [Related]

  • 24. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
    He HQ, Wu YX, Nie YJ, Wang J, Ge M, Qian F.
    Acta Pharmacol Sin; 2017 Mar 24; 38(3):342-350. PubMed ID: 28112185
    [Abstract] [Full Text] [Related]

  • 25. SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells.
    Huang X, Zhu J, Jiang Y, Xu C, Lv Q, Yu D, Shi K, Ruan Z, Wang Y.
    Drug Des Devel Ther; 2019 Mar 24; 13():1763-1772. PubMed ID: 31213766
    [Abstract] [Full Text] [Related]

  • 26. Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.
    Chen G, Xiao B, Chen L, Bai B, Zhang Y, Xu Z, Fu L, Liu Z, Li X, Zhao Y, Liang G.
    Eur J Med Chem; 2017 Oct 20; 139():726-740. PubMed ID: 28858767
    [Abstract] [Full Text] [Related]

  • 27. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
    Zhang Y, Chen H, Zhang W, Cai Y, Shan P, Wu D, Zhang B, Liu H, Khan ZA, Liang G.
    Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165683. PubMed ID: 31953218
    [Abstract] [Full Text] [Related]

  • 28. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
    Han XZ, Ma R, Chen Q, Jin X, Jin YZ, An RB, Piao XM, Lian ML, Quan LH, Jiang J.
    J Ethnopharmacol; 2018 May 10; 217():220-227. PubMed ID: 29476961
    [Abstract] [Full Text] [Related]

  • 29. Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2).
    Zhu W, Wang M, Jin L, Yang B, Bai B, Mutsinze RN, Zuo W, Chattipakorn N, Huh JY, Liang G, Wang Y.
    Br J Pharmacol; 2023 Apr 10; 180(8):1114-1131. PubMed ID: 36480410
    [Abstract] [Full Text] [Related]

  • 30. Erlotinib Protects LPS-Induced Acute Lung Injury in Mice by Inhibiting EGFR/TLR4 Signaling Pathway.
    Tao H, Li N, Zhang Z, Mu H, Meng C, Xia H, Fu L, Xu Y, Zhang S.
    Shock; 2019 Jan 10; 51(1):131-138. PubMed ID: 29438224
    [Abstract] [Full Text] [Related]

  • 31. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
    Wang C, Zeng L, Zhang T, Liu J, Wang W.
    Eur J Pharmacol; 2016 Oct 15; 789():172-178. PubMed ID: 27450485
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
    Zhang Z, Chen N, Liu JB, Wu JB, Zhang J, Zhang Y, Jiang X.
    Mol Med Rep; 2014 Jul 15; 10(1):101-6. PubMed ID: 24818579
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
    Chen XY, Dou YX, Luo DD, Zhang ZB, Li CL, Zeng HF, Su ZR, Xie JH, Lai XP, Li YC.
    Int Immunopharmacol; 2017 Sep 15; 50():270-278. PubMed ID: 28711783
    [Abstract] [Full Text] [Related]

  • 38. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
    Chen X, Yang X, Liu T, Guan M, Feng X, Dong W, Chu X, Liu J, Tian X, Ci X, Li H, Wei J, Deng Y, Deng X, Chi G, Sun Z.
    Int Immunopharmacol; 2012 Oct 15; 14(2):209-16. PubMed ID: 22835426
    [Abstract] [Full Text] [Related]

  • 39. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress.
    Su ZQ, Mo ZZ, Liao JB, Feng XX, Liang YZ, Zhang X, Liu YH, Chen XY, Chen ZW, Su ZR, Lai XP.
    Int Immunopharmacol; 2014 Oct 15; 22(2):371-8. PubMed ID: 25068825
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.